mercredi 20 novembre 2013

OpenStack brings agility to the enterprise

In his keynote at the OpenStack Summit in Hong Kong earlier this month, Jonathan Bryce, the director of the OpenStack Foundation, referenced a user poll identifying the top 10 environments within which OpenStack was being deployed. Not surprising was that the usage today is for web applications, agile development and DevOps.

What did not get coverage is how IBM is adopting OpenStack in the enterprise, bringing the same agility and flexibility of commodity cloud to enterprise systems. In October, IBM announced Power Virtualization Center (PowerVC) as the management center for PowerVM. Credit where credit is due, VMware has done a great job with vCenter, providing an easy-to-use, administrator-friendly approach to ESX virtualization management. PowerVC seeks to do the same for PowerVM and IBM Power Systems.

Built on the OpenStack Havana release, PowerVC uses the core Cinder, Nova and Neutron management components of OpenStack to manage the provisioning and configuration of LPARs, the creation and allocation of storage LUNs to LPARs and the assignment of IP addresses and VLANs. Initial storage support is for IBM Storwize V7000 and SAN Volume Controller (SVC), directly allocating LUNs to LPARs via NPIV. Support for Shared Storage Pools (SSP) and other storage devices with OpenStack Cinder device drivers are also in plan.

Power administrator productivity is greatly improved. Finally they can allocate LPARs with SAN attached storage in one go. The waiting for storage admins to map and assign LUNs to the dynamically created NPIV WWNs is eliminated. Even more impressive is the ability to manage LUN reassignment during Live Partition Migration (LPM) of LPARs from one system to another. Remapping LUNs from the source system to the target system as required and validating the configuration to ensure success of the live LPAR migration.

PowerVC 1.2 is available in December 2013. In the meantime, you can find more information on IBM Developer Works and a sneak preview on YouTube.



By: Steve Strutt

The Gap in skills for mobile, social, analytics continues !

Skills have been quite the topic lately.  Why?  We have such skills gaps that any great company must really address the challenge, with the industry.

Here’s the results of the study that show the gaps !

Read last week’s blogs for IBM’s focus with the academic universities in security and analytics !

Vidéo link: http://www.youtube.com/watch?v=sdnFtmeVqg0




From: Sandy Carter blog
Link: http://socialbusinesssandy.com/2013/11/18/3190/


AMD, Cray, IBM, Intel and Nvidia Receive $25.4 Million in Contracts for Exascale Supercomputer Interconnect Design.

The Department of Energy’s (DOE) office of science and the national nuclear security administration (NNSA) have awarded $25.4 million in research and development contracts to five leading companies in high-performance computing (HPC) to accelerate the development of next-generation supercomputers.

Under DOE’s new DesignForward initiative, AMD, Cray, IBM, Intel Federal and Nvidia will work to advance extreme-scale, on the path to exascale, computing technology that is vital to national security, scientific research, energy security and the nation's economic competitiveness.

Exascale Computing Is Crucial

“Exascale computing is key to NNSA’s capability of ensuring the safety and security of our nuclear stockpile without returning to underground testing. The resulting simulation capabilities will also serve as valuable tools to address nonproliferation and counterterrorism issues, as well as informing other national security decisions,” said Robert Meisner, director of the NNSA office of advanced simulation and computing program.

As the nation’s largest funder of physical science research, DOE provides thousands of researchers at national labs and universities with access to some of the world’s most powerful supercomputers. These systems, which have peak speeds of quadrillions of calculations per second, are helping scientists study climate change, develop renewable energy sources, understand the makeup of our universe and develop new materials. But taking these research missions to the next level will require supercomputing systems that are 1000 times faster than today’s systems.



“In an era of fierce international HPC competition, the development of exascale computing becomes critical not only to our national security missions but to the nation’s economic competitiveness in the global marketplace. This partnership between industry, the DOE Office of Science and NNSA supports the development of technology to overcome the obstacles on the road to exascale systems,” said William Harrod, FastForward program manager and research division director for DOE’s advanced scientific computing research program.

DesignForward Initiative

The DesignForward contracts, which cover a two-year performance period, will support the design and evaluation of interconnect architectures for future advanced HPC architectures. Such interconnects will tie together hundreds of thousands or millions of processors, as building blocks of supercomputers to be used in studying complex problems in unprecedented detail. The DesignForward focus will be on developing interconnects that are energy efficient, have high bandwidth, and minimize the time to move data among processors.

“A major disruption is facing high performance computing because energy constraints are causing our building blocks, microprocessors and memory to change dramatically. We need to collaborate with computer companies to ensure that future supercomputers meet DOE's mission needs in science, energy and national security. Berkeley Lab is pleased to place these contracts on behalf of DOE and its laboratories,” said Sudip Dosanjh, director of the national energy research scientific computing center at Lawrence Berkeley national laboratory (Berkeley Lab).



DesignForward is the follow-on to DOE’s FastForward project, a public-private partnership between DOE and HPC industry to advance extreme scale computing technologies with the ultimate goal of funding innovative, critical R&D technologies needed to deliver next generation capabilities within a reasonable energy footprint. FastForward is funded by DOE's Office of Science and NNSA, and technically managed by seven national laboratories.

Successful Public-Private Partnership

Under the new contract, Intel will focus on interconnect architectures and implementation approaches, Cray on open network protocol standards, AMD on interconnect architectures and associated execution models, IBM on energy-efficient interconnect architectures and messaging models and Nvidia on interconnect architectures for massively threaded processors.

“We are honored to be selected for this research program and to continue our work with DOE to shape the future of high-performance computing, started last year with FastForward. This public-private partnership extends AMD’s research into the use of next generation APUs to meet the demands of extreme-scale computing. We believe this program will benefit the DOE and provide technology insights into challenges throughout the computing industry,” said Alan Lee, AMD’s corporate vice president of research and advanced development.

The vendors will collaborate with DOE's exascale co-design centers to determine how changes in the system architectures will affect how well the scientific applications perform.

“U.S. leadership in HPC is essential to meeting the mission-critical needs of DOE and other federal agencies. We are proud to have been chosen by DOE as a continued partner in their strategic work toward the advancement of next-generation supercomputing technology. Intel has a long standing commitment to science, research and innovation, from supercomputing to personal computing,” noted Dave Patterson, president of Intel Federal.

“Partnerships and collaborations are an important element of exploring new ideas and overcoming the challenges of exascale computing, and we look forward to working with the DOE researchers and playing a role in the co-design efforts that will be key to the success of the DesignForward program,” said Peg Williams, Cray’s senior vice president of high performance computing systems.

“Exascale computing is vitally important for U.S. scientific research and economic competitiveness, and Nvidia’s expertise in massively-parallel heterogeneous systems will play a critical role in reaching exascale. Interconnection networks are a key component of exascale systems. We are excited to collaborate with other DesignForward recipients to enable an open ecosystem for next-generation high-performance system interconnects,” noted Bill Dally, chief scientist and senior vice president of research at Nvidia



By: Anton Shilov
Link: http://www.xbitlabs.com/news/other/display/20131115202502_AMD_Cray_IBM_Intel_and_Nvidia_Receive_25_4_Million_in_Contracts_for_Exascale_Supercomputer_Interconnect_Design.html



 

 

lundi 18 novembre 2013

IBM Neo Heats Up Competition in BI Search

I wrote last week that one of the big trends in big data was a resurgence in the use of search and natural language processing for making BI as easy as Google. Last week at IBM's annual Information on Demand conference, IBM announced project Neo, heating up competition in BI Search and cloud BI.

Neo starts with a simple search box in which users can ask a question. In this screenshot, "what is the relationship between Budget, Gross Domestic Sales, by Story type. Neo will present a list of possible data sources that can answer the question. For now, these data sources are restricted to data sets loaded to the cloud, in a DB2 columnar data store. IBM concedes that for the product to be fully embraced, Neo will need to support on-premise data sources as well, and has said that is part of the product roadmap. 

Once the user selects the optimum data source, Neo generates an interactive visualization. For example, a user can refine the question by change "budget" to "units sold," for example. The visualization can also be changed to display as a trend rather than a bubble chart. In addition to the visualization, Neo generates a number of infographics (shown along the top)based on statistical algorithms that might be relevant. So even though the user didn't ask about seasonality, the data is showing there is a pattern with Fall being the best season for sales (early holiday shoppers, perhaps?).

Neo brings together a lot of intellectual property that IBM has acquired in recent years. The visualizations are powered by RAVE (Rapidly Adaptive Visualization Engine) technology and skills acquired through SPSS. The infographics are based on some of the capabilities in Analytic Catalyst, a module released in June of this year that makes advanced analytics easy for a casual business user. The natural language processing leverages Vivisimo, later rebranded Infosphere Data Explorer.

Not surprisingly, the initial demos of Neo are impressive. It's easy, visual, and powerful, for the most casual of decision makers. It could do for data what Google has done for the Internet. Today, the industry average for BI adoption is at 24% of employees, and ease of use is an oft-cited barrier to broader BI (take this year's survey to rate your BI adoption and ease of use).

What wasn't shown, though, is how the data sources get indexed and loaded to the cloud. IBM Cognos has previously tried to leverage the simplicity of search with its Go! Search interface launched in 2006. With that tool, content in PowerCubes and reports had to be indexed on a periodic schedule. Search was limited to key words, and the interface was existing reports, not nearly as visual as Neo. So Go! Search had a degree of complexity to implement, was less intuitive, appealing, and smart. Perhaps these are all reasons why it wasn't widely adopted? Just how well Neo overcomes the past limitations of Go! Search will only be known once the beta launches in January.

IBM also announced another new product, IBM Concert, that brings collaboration, workflow, and mobile together in a SaaS solution. This product is expected to be available in December. I see collaboration as still an emerging capability that customers are trying to figure out. Recognizing the influence that vendors like Facebook and Twitter have had on consumers, social and collaboration capabilities have began appearing in BI tools and enterprise apps a few years ago. SAP first launched Streamwork, then later acquired Success Factor's Jam, while Microsoft acquired Yammer, and TIBCO launched Tibbr. IBM has had strong collaboration capabilities in its Lotus Connections product, whose technology was first integrated with IBM Cognos in its version 10 release back in 2010. But I haven't found a single customer using those capabilities. Again, it's not clear if that's because it was poorly marketed and BI teams have other priorities, or if it reflects a larger, industry-wide problem. Collaboration around data today is usually offline from the data, whether via email or in meeting rooms or conference calls. So first, capturing comments in collaboration software is a change in the current work flow. Second, making comments publicly requires an analytic culture in which it's safe to voice opinions, dissentions, and to ask tough questions. Just imagine, if 30 years ago, the engineer who was worried about the Space Shuttle Challenger posted a comment in the data analysis of O-ring tests to the effect of, "the data shows we shouldn't launch. Too cold out." In those days, the engineer could barely voice a concern in whispers and only to his direct supervisor. (If you're as fascinated about that story, culture, and decision making catastrophe as I am, I'll be watching the Science Channel's documentary this Saturday). How far have we come since then? Is social something reserved more for personal and public opinion, or is it something that the industry is ready to embrace in BI?



By: Cindi Howson
Link: http://biscorecard.typepad.com/biscorecard/2013/11/ibm-neo-heats-up-competition-in-bi-search.html

IBM acquires Fiberlink as mobile-security strategy keystone

IBM Wednesday announced an agreement to acquire Fiberlink Communications, saying the purchase is a key part of a broader mobile-security strategy to provide assurance in transactions conducted via devices such as iPhones and Android smartphones.

Fiberlink provides mobile-device management (MDM) through its MaaS360 cloud-based offering, counting about 3,500 customers in industries that include financial services, healthcare and manufacturing. IBM's director of application data and mobile security Caleb Barlow says the acquisition, expected to be concluded shortly, puts IBM on a path to compete with MDM vendors such as, Symantec, AirWatch, MobileIron and Good Technology.

But Barlow also points out that Fiberlink should be considered part of IBM's broader strategy for mobile-device security, which includes IBM's recent acquisition of Trusteer, the security firm specializing in an anti-fraud, anti-malware approach that has been used in the banking industry in particular on the Web.

Through Fiberlink and Trusteer combined, "which is the key part of this,"  he says, IBM intends to provide a type of trust assurance in transactions done on mobile devices in business-to-business or business-to-consumer communications. With the Fiberlink acquisition, IBM is also solidifying its approach to supporting "Bring Your Own Device" environments.  

IBM's intention is to develop a unified mobile-security framework through cloud- and agent-based means that provides not just management of devices but security checks against malware or device hijacking, for example, especially during any sensitive transaction process.

In addition, the goal would be to enable transmission of relevant mobile-device security-event information to IBM's security information and event management tool, QRadar.

Barlow acknowledges there is "some overlap" in what Fiberlink can provide in application management and IBM's managed mobile security service started two years ago. "But it's fairly minimal," he says. IBM's main focus going forward is Apple iOS, and Android, "but we're also looking at Windows Mobile."



By: Ellen Messmer
Link: http://news.techworld.com/security/3489128/ibm-acquires-fiberlink-as-mobile-security-strategy-keystone/

The promise of software defined storage is for companies of all sizes

Software defined storage is a new concept for some providers—but not for IBM Storage. The first step in software defined storage is virtualization, which IBM has been offering for 10 years. When you virtualize your storage, data on all your storage from any storage company can be managed as a single pool of data with the same management interface with the same capabilities. The benefits of this are huge, including:
  • 47 percent reduction in time spent managing storage
  • 30 percent reduction in storage capacity growth

IBM’s newest member of the Storwize Family, the IBM Storwize V5000, makes software defined storage more affordable than ever. Any size company can now afford to experience the benefits of storage virtualization.

In addition, the Storwize V5000 has capabilities common to the Storwize family like Easy Tier automated tiering, thin provisioning and advanced remote mirroring and FlashCopy for data protection. This video covers these benefits (link: http://www.youtube.com/watch?v=Eq53TmFuvnI)

I mentioned that IBM Storage has supported the first step in software defined storage—storage virtualization—for many years. The Storwize V5000 also supports the next step: opening up the platform to allow others to provide innovation. The Storwize family now supports IP replication to reduce the cost of remote mirroring. In addition, SANSlide technology from a company called Bridgeworks is included to reduce network costs even further by increasing the utilization of the network.

This exactly defines the promise of software defined storage. When you virtualize your storage with the Storwize V5000, all of your storage can now get the benefits of IBM innovation like Easy Tier or innovation from other companies like Bridgeworks.

It’s one thing to get a storage system with advanced capabilities, but when your storage can give other storage systems advanced capabilities they didn’t have before, that’s simply amazing.

Check out the below infographic, and then let me know: What storage management challenges is your company facing?





By: David Vaughn
Link: http://www.smartercomputingblog.com/smarter-storage/software-defined-storage/


IBM bets on big data visualization

IBM broadened its big data portfolio with a series of software enhancements as well as visualization tools that are aimed to bring analytics to the enterprise masses.

The company rolled out the additions as it kicked off its Information On Demand Conference in Las Vegas.

IBM touted visualization as a key differentiator and its technologies such as Project Neo, software that takes raw big data logs and puts them into a graphical interface. Project Neo will be in beta in early 2014.

What IBM is gunning for is applications that can bring big data to your average marketing manager. Big Blue noted its Rapidly Adaptive Visualization Engine (RAVE) can provide analytical graphics for human resources, marketing and sales on any device.

Another visualization effort is IBM Concert on Cloud, which is a social analytics platform for remote employees on mobile.

Among the notable product points:
  • IBM launched an analytics cloud tool dubbed SmartCloud Analytics-Predictive Insights. With the software, enterprises can comb through terabytes of IT operations data in real time and head off problems before they become too large. The analytics technology runs on IBM's recently acquired SoftLayer infrastructure.
  • The company also launched a new version of its SmartCloud Virtual Storage Center, which automates tiering and moves resources to cloud storage. The software learns patterns over time.
  • Meanwhile, IBM sprinkled its BLU Acceleration technology throughout its portfolio. BLU Acceleration is meant to be use with in-memory systems and has been added to IBM's Power Systems as well as PureSystems.
  • InfoSphere Data Explorer will get a big data search tool using visualization tools.
  • InfoSphere Data Privacy for Hadoop will allow customers to anonymize data in Hadoop, NoSQL and relational systems.
  • PureData System for Hadoop has built in archiving tools, administration and security levels.


By: Larry Dignan
Linkhttp://www.zdnet.com/ibm-bets-on-big-data-visualization-7000022741/

IBM and University Hospital Zurich to Collaborate on Tool for Diagnosing Cancer

IBM scientists are collaborating with pathologists at the University Hospital Zurich to test a new prototype tool to accurately diagnose different types of cancer.

According to a release, this work is based on a technology developed by IBM scientists called a microfluidic probe, which slightly resembles the nib of a fountain pen.

A critical step in the diagnosis of cancer is the analysis of a patient's biopsy tissue sample, which sometimes can be as small as a pinhead. Even with such a small sample, pathologists can test for the absence or presence of tumor cells and provide information pertaining to the course of treatment to doctors.

To analyze samples, pathologists typically stain the tissue sample with liquid reagents. The intensity and distribution of the color stain classify and determine the extent of the disease. While this approach provides insights into the tumor, it is increasingly being realized that significant variations exist within the tumor itself; mapping these variations may help understand the drivers for each tumor, and consequently assist in personalizing treatment strategies.

IBM scientists have developed a technology called a microfluidic probe which can interact with tissue sections at the micrometer scale to help unravel some of the molecular variations within tumors.

The collaboration between IBM and the University Hospital Zurich puts an emphasis on uncovering the heterogeneity of tumors. More specifically, the collaboration focuses on lung cancer, which is one of the most prevalent forms of cancer and has a high mortality rate.

"Pathologists are determined to obtain as much accurate information as possible from markedly small biopsy samples," said Alex Soltermann, a pathologist specializing in lung cancer at the Institute for Surgical Pathology of the University Hospital Zurich. "We hope to introduce new technologies, such as the microfluidic probe, into the clinical molecular pathology diagnostic framework to enable a range of investigations, which were previously thought to be infeasible. If we are successful, the tool will be a driver for personalized medicine, and translate into increased confidence in diagnosis and better detection of predictive cancer markers."

Peter Schraml, director of the tissue biobank at the Institute of Surgical Pathology, University Hospital Zurich, said, "In addition to assisting in diagnostics, this tool may provide insight into the biomarker distribution in tumor tissues, which can aid in understanding cancer progression."

The eight-millimeter-wide, diamond-shaped probe consists of a silicon microfluidic head ending with a small tip bearing two microchannels.

"For about a year we have been testing the probe in our lab, and initial results are very encouraging we are now developing the technology in the context of important aspects in pathology," said Govind Kaigala, a scientist at IBM Research Zurich. "Over the next several months, we will install a prototype device at the hospital and work alongside pathologists."

The tool which houses the microfluidic probe is roughly the size of a tissue box it is now at stage where it may assist in studying the distribution of low numbers of cancer cells in biopsied samples.

The probe injects very small volumes of reagents on the tissue surface and then continuously aspirates the reagents to prevent spreading and accumulation. This approach is used to deliver and retrieve reagents locally in selected areas of a tissue section with pinpoint accuracy. This local interaction with the tissue sample helps in mapping the heterogeneity in the tissue.

"We are very excited to partner with IBM on the microfluidic probe technology to develop techniques for its use in the clinical pathology framework this is a fine example of a translational research that could also help answer some basic science questions," said Holger Moch, head of the Institute of Surgical Pathology at the University Hospital Zurich.

The microfluidic probes are designed and manufactured at the Binnig and Rohrer Nanotechnology Center on the campus of IBM Research - Zurich.

This research collaboration is funded by SystemsX.ch, the Swiss initiative in systems biology.
 
 
 
By: Professional Services Close - Up
 

IBM vision for computer of the future

International computer giant IBM has unveiled its vision for a "supercomputer in a sugarcube" powered by "electronic blood".

The aim is to base the design on the workings of the human brain in order to surmount some of the difficulties - delivering power and removing the excess heat - that computer engineers are currently encountering as they seek to make chips smaller and faster. 

The heat problem effectively doubles the running cost of a computer, because nearly as much energy has to be spent on cooling as on computing. 

Current figures suggest that just running the Internet accounts annually - in energy terms - for an equivalent amount of CO2 as the airline industry, and computing generally equates to a global spend of over $30 billion just making hot air. 

But, to make processors more compact and run even faster, chips will need to shrink, partly to reduce the distances - and hence time - over which information needs to be transmitted and to pack in more processing power. Doing so, though, will intensify the present problems. 

So IBM have turned to the human brain for inspiration because, despite consuming energy at the rate of only about 20 watts, the brain is, according to IBM researchers Patrick Ruch and Bruno Michel, "10,000 more dense and efficient than any computer around today." 

This they put down to the fact that the brain solves several problems in one: the 3D structure of the brain makes it highly compact, and it uses a highly efficient circulatory (blood) system to deliver energy and keep the operating environment right for optimal performance of the components. 

According to Michel, the brain uses "40% of its volume for function and 10% for energy and cooling." The best current computers, on the other hand, devote only about 1% to processing! 

Instead, Michel and Ruch propose to pile up processors like the chip equivalent of a skyscraper to boost computing power; then, they'll keep them cool by circulating a fluid - "electronic blood" - through special channels within the chips to soak up heat; and - here's the really clever bit - they'll also use the same fluid to power the chips using a chemical reaction. 

Analogous to blood delivering sugar to hungry neurones, the approach being explored at IBM is to use a solution of a chemical like vanadium that can be "charged" before it is pumped into the computer. 

Then, as it passes over the processor components, the vanadium alters its chemical oxidation state, releasing electrons to the transistors to power them. 

The ultimate goal is to cram a super-computer that currently occupies half a football pitch into a volume the size of a sugarcube by 2060.



By: Chris Smith


IBM Corporation Research and Institute of Bioengineering and Nanotechnology Discover Breakthrough for Breast Cancer Drug Delivery

Today, scientists from IBM and Singapore's Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first biodegradable, biocompatible and non-toxic hydrogel that can deliver treatment more efficiently to people fighting breast cancer. 

Approximately 25% of all breast cancer patients have human epidermal growth factor receptor 2 (HER2), a specific type of cancerous cell identified in this study that is considered aggressive because it spreads quickly and has a low survival rate.

Treatment of breast cancer varies according to the size, stage and rate of growth, as well as the type of tumor. There are currently three main categories of post-surgery therapies available: hormone blocking therapy, chemotherapy and monoclonal antibodies (mAbs) therapy.

In the case of antibodies, the drugs are paired with saline and delivered intravenously into the body. Targeting specific cells or proteins, the antibodies block specific cell receptors to destroy cancer cells and suppress tumor growth. However, these drugs are absorbed in the body and have limited lifetimes and effectiveness when injected directly into the bloodstream.

Recognizing this, IBM and IBN scientists developed a novel synthetic hydrogel made up of over 96% water and a degradable polymer that is capable of sequestering a range of cargos from small molecules to large molecules including mAbs.

It also exhibits many of the biocompatible characteristics of water-soluble polymers, which hold form in the body without completely dissolving. This allows the hydrogel to function as a depot for the drug to slow-release its contents in a targeted location directly at the tumor site over weeks instead of days. Once the drug has been delivered, the hydrogel biodegrades naturally and passes through the body.

"Drawing from our experience in materials innovation for electronics technology, we are now applying these techniques to the quest for improved health," said Dr. James Hedrick, Advanced Organic Materials Scientist, IBM Research Almaden. "This hydrogel can help deliver drugs over an extended period of time without causing a significant immune response, effectively sending its contents directly to the tumor without harming healthy surrounding cells."


In animal studies done by Singapore's IBN, testing demonstrated improved results when the antibody was paired and delivered with the hydrogel, even at low concentration, than on its own.
  • Tumor Size: Over the course of 28 days, the tumor shrank 77% when paired with the hydrogel via subcutaneous injection at the tumor site as opposed to 0% without it by intravenous injection.
  • Treatment Frequency: When paired with the hydrogel and injected subcutaneously at a site far away from the tumor, the treatment frequency was reduced from 4 to 1 while maintaining a similar therapeutic effect. This is when compared to just the antibody solution formulation injected intravenously.
  • Weight: The ability to target and deliver the drug directly at the tumor site allowed for only the infected cells to be eradicated, leaving healthy cells alone. This resulted in stable to moderate weight gain during the study instead of massive weight loss traditionally associated with cancer drug treatments.
  • Non-Toxic: Since the hydrogel is non-toxic, it demonstrated high biocompatibility as evidenced by no cellular inflammation with minimal immune system response while degrading naturally and passing through the body within 6 weeks
"We have developed new, effective materials for nanomedicine, which has been one of IBN's key research focus areas since 2003. The sustained delivery of Herceptin from our hydrogel provides greater anti-tumor efficacy and reduces injection frequency. Thus, our approach may help to improve patient compliance, offering a better alternative to existing breast cancer treatments. This technology can also be used to deliver other types of antibodies or proteins to treat different diseases," said Dr. Yi Yan Yang, Group Leader, Nanomedicine, Institute of Bioengineering and Nanotechnology, Singapore.

The IBM nanomedicine polymer program - which started in IBM's Research labs four years ago with the mission to improve human health stems from decades of materials development traditionally used for semiconductor technologies. This advance will expand the scope of IBM and the Institute of Bioengineering and Nanotechnology's collaborative program, allowing scientists to simultaneously pursue multiple methods for creating materials to improve medicine and drug discovery. An industry and institute collaboration of this scale brings together the minds and resources of several leading scientific institutions to address the complex challenges in making practical nanomedicine solutions a reality.




Linkhttp://www.devicespace.com/news_story.aspx?full=1&StoryID=313988